Scholar Rock Holding Corp at Citi Global Healthcare Conference Transcript
Andrew Pucher. I'm a member of the Citi Biopharma Investment Banking team here. Very pleased to be joined this afternoon by David Hallal and Vikas Sinha of Scholar Rock. And so why don't we get into it with a little bit of Q&A around the company, your data, how to think about the path to commercial launch and beyond.
Maybe just opening remarks, I'll open it up for you guys, a little bit on your background and how you got involved and what you saw at Scholar Rock to get you involved in your current executive roles would be good context. And then maybe some opening remarks, David, from you in terms of how investors should think about the positioning of Scholar Rock today.
Great. Thanks, Andrew. It's fantastic for Vikas and I to be here at the Citi Healthcare Conference in Miami. As you know, Andrew, this has been really a transformative 12, 14 months for the company, really starting with the readout of our Phase III trial in October of 2024,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
